Back to News
Teva Pharmaceutical Industries announced it will begin direct trading on the NYSE, transitioning from its current American Depositary Shares structure. The announcement is a listing-structure and trading-access change, with no operating, earnings, or financial guidance updates disclosed in the article excerpt.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.05
Ticker Sentiment
TEVA0.35
More News
- Grab aims for 'next level' in financial services with purchase of buy-now pay-later platform Atome
- China's AI leaders keep quiet despite U.S. 'publicity' on tech risks
- Exclusive-Malaysia talks to rival airlines as it monitors AirAsia’s financial health, sources say
- China’s slower loan growth is the new normal, central bank governor says
- ‘The end of the keyboard is near’: Christian Klein predicts voice translation will be the next workplace advantage
- Axon prices $1 billion convertible notes offering due 2031